Skip to content

Clinical trials

Phase 2 Metabolic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 2 Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20072
20084
20091
20102
20111
20121
20131
20142
20151
20161
20171
20181
20204
20213
20223
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting4
Terminated4
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Akcea Therapeutics2
University of Alabama at Birmingham2
VIVUS LLC2
89bio, Inc.1
Albert Einstein College of Medicine1
Alexion Pharmaceuticals, Inc.1
Calibra Medical, Inc.1
Caliway Biopharmaceuticals Co., Ltd.1
Catabasis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases35
Diabetes Mellitus11
Glucose Metabolism Disorders9
Lipid Metabolism Disorders9
Dyslipidemias8
Diabetes Mellitus, Type 27
Endocrine System Diseases6
Hyperlipidemias5
Cardiovascular Diseases4
Hypercholesterolemia4

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.